![](https://img.einnews.com/small/700654/netherton-syndrome-market-forec.jpeg)
Netherton Syndrome Treatment Market 2032: FDA Approval, Clinical Trials, Pipeline, Prevalence, Companies by DelveInsight
Netherton Syndrome companies are Quoin Pharmaceutical’s, Boehringer Ingelheim’s, LifeMax Laboratories, Novartis, Azitra Inc and others. ALBANY, NEW YORK, UNITED STATES, July 4, 2024 /EINPresswire.com/ -- DelveInsight’s “Netherton Syndrome Market …